NCT02986646

Brief Summary

Lateral epicondylitis, commonly known as "tennis elbow" is a common cause of elbow pain encountered in primary care and specialty clinics. Although lateral epicondylitis is common, little consensus exists on the best way to treat it. Historically 80% of patients will get better with non-operative treatments (rest, NSAIDS, bracing and injections). In regard to efficacy of injections, recent large, prospective, randomized studies have shown minor improvements in the short term, but no long term benefits when compared to saline injection. Consistently, intra-articular injections have not been reported. The investigators suspect that elbow joint inflammation may be an underappreciated source of pain in lateral epicondylitis. The investigators' hypothesis is that patients receiving intra-articular injections will have greater improvement compared to patients receiving either no injection or an intra-tendinous injection.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 8, 2016

Completed
24 days until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2020

Completed
Last Updated

May 13, 2021

Status Verified

May 1, 2021

Enrollment Period

3.1 years

First QC Date

November 17, 2016

Last Update Submit

May 10, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • PRTEE (Patient Rated Tennis Elbow Evaluation)

    The primary analysis will compare the PRTEE scores of each group at 2 years post-enrollment.

    2 years

Study Arms (3)

physical therapy (PT) and rest

This group of subjects will be prescribed a physical therapy home exercise program and rest (of the injured elbow).

PT and intra-tendinous steroid injection

This group of subjects will be prescribed a physical therapy home exercise program and will received an intra-tendinous corticosteroid injection into the area of the ECRB origin (of the injured elbow).

PT and intra-articular steroid injection

This group of subjects will be prescribed a physical therapy home exercise program and will received an intra-articular corticosteroid injection into the elbow joint (of the injured elbow).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who are seeking care from either a primary care sports medicine physician or orthopaedic surgeon for their persistent and limiting elbow pain.

You may qualify if:

  • Confirmed diagnosis of lateral epicondylitis based on 2 or more of the following diagnostic criteria: tenderness over the lateral epicondyle; pain with resisted wrist extension; pain with resisted long finger extension.
  • Symptoms lasting a minimum of 6 weeks
  • Pain score of \>= 3/10 using the Visual Analog Scale (VAS)
  • Age \>= 18 years

You may not qualify if:

  • History of prior elbow surgery
  • History elbow fracture within the past year
  • Elbow instability on physical examination
  • Elbow arthritis on radiographs
  • Compressive neuropathy in the affected extremity (i.e.carpal tunnel, cubital tunnel)
  • Evidence of cervical myelopathy, radiculopathy or brachial plexopathy
  • History of systemic inflammatory condition (i.e. rheumatoid arthritis or systemic lupus erythematosus)
  • Allergy to study administered medications (steroid or lidocaine)
  • Neoplasm
  • Non-English speaking patients
  • Inability to comply with study protocols and follow up.
  • Pregnant female

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Truman Medical Center

Kansas City, Missouri, 64108, United States

Location

MeSH Terms

Conditions

Tennis Elbow

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Study Officials

  • Akin Cil

    University of Missouri Kansas City, Department of Orthopaedic Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Franklin D. Dickson Associate Professor, Vice Chairman, Department of Orthopaedic Surgery, Truman Medical Centers

Study Record Dates

First Submitted

November 17, 2016

First Posted

December 8, 2016

Study Start

January 1, 2017

Primary Completion

January 20, 2020

Study Completion

January 20, 2020

Last Updated

May 13, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations